SEC Form 4 · accession 0001209191-16-121381
TETRAPHASE PHARMACEUTICALS INC · TTPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Guy Macdonald
Officer — President and Chief Executive · Director
Period of report
May 16, 2016
Accepted (ET)
May 18, 2016 · 5:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001373707
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 16, 2016 | M | 25,323 | $0.87 | A | 90,757 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $0.87 | May 16, 2016 | M | 25,323 | A | — | Sep 10, 2019 | Common Stock | 25,323 | 20,000 | D |
Explanation of responses
- F1The amount of securities beneficially owned by the reporting person following the transaction reported on this Form 4 reflects the purchase by the reporting person of 312 shares of common stock on November 13, 2015 and 1,122 shares of common stock on May 13, 2016, both pursuant to the issuer's 2014 Employee Stock Purchase Plan.
- F2These options are fully vested.